wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33583275-05906B36-0E3A-4764-8EA8-CDD94DBD2B5E
Q33583275-05906B36-0E3A-4764-8EA8-CDD94DBD2B5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33583275-05906B36-0E3A-4764-8EA8-CDD94DBD2B5E
Eribulin Approval in Advanced Liposarcoma - Successful Drug or a Weaker Methodology?
P2860
Q33583275-05906B36-0E3A-4764-8EA8-CDD94DBD2B5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33583275-05906B36-0E3A-4764-8EA8-CDD94DBD2B5E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f57e1bd0af9af68cdd3d1a05d99cca3b717feba
P2860
Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agents.